Results with Lifescozul™Brain Cancer
Introduction to the case
False expectations are almost always as terrible as cancer. LifEscozul Group pays special attention to be as realistic as possible with both the patient and family members.
To enter our protocol it is necessary to evaluate each case carefully. Many of our patients come to us with advanced or very advanced disease development.
Each case analysis involves the definition of parameters that allow us to measure the effectiveness of LifEscozul treatment not only for us but also for the patient himself.
Today we are going to talk about one of the types of tumor where we have been most successful in the treatment with LifEscozul (escozul, blue scorpion venom): Glioblastoma.
The patient in question has been under treatment for 5 years. Learn more about the results achieved.
Lenin Alvia Cusme, Male, 47 years old at the beginning of treatment with LifEscozul.
He presented with severe headaches, insomnia, dizziness, mild respiratory distress and speech problems.
It was initially diagnosed as Brain Cancer Left Parietal Anaplastic Anaplastic Astrocytoma Brain Cancer Grade III, and later as Left Parietal Glioblastoma Multiforme.
Lenin had undergone surgery in July 2014 for a high grade astrocytoma with partial resection.
After surgery he received radiotherapy between November and January 2015, and chemotherapy with temozolamide.
After surgery the doctors established that he was left with a general disability of 70% and 40% of speech. In addition, he was given a survival period of 1 to 2 years, since for this type of case there is a high probability that the tumor will develop again and be much more aggressive.
This was the scenario when Mr. Lenin came to us.
Evolution with LifEscozul™ and actual results
The first contact about the case came from Mr. Lenín's wife, who has maintained a fluid contact which has been fundamental as we will see. The analysis we made of the case initially told us that the probabilities of obtaining a good result and an improvement in the quality of life were of 20%.
And so we informed Mr. Lenín and his family, because we must always be realistic with the patient and tell the truth above all kinds of illusions.
But this time the probability was not fulfilled.
The initial proposed dose was high. Once the doctor was assigned, we proceeded to controls and periodic interviews with the family.
This is her evolution of 5 years in LifEscozul treatment (blue scorpion venom, blue scorpion, escozul) which began in March 2015.
45 days in treatment with LifEscozul, first reports:
A month and a half into treatment we received an update on symptoms, indicating that the severe headache was gone and she had improvements in speech.
90-120 days on LifEscozul treatment:
At 3 months of treatment in terms of symptoms Mr. Lenin continued to gradually improve, still with dizziness but had better articulation of words, milder and sporadic pain and easier breathing.
At 4 months of treatment, in July, the patient continued to be stable, presenting with dizziness only sporadically.
Semiannual Review September 2015:
After 6 months on treatment we proceeded to perform an assessment. At this point, Mr. Lenín's quality of life had stabilized, he continued well and with no negative changes in his situation.
It was decided on our part to be more aggressive and we proceeded to a progressive increase in the concentration of the dose every three months, seeking to maintain and improve results also knowing how aggressive this type of tumor is.
In the following report of November 2015 there was no change in Lenin's situation, the wife commented that he was well and without symptoms.
By December Lenín was well, again without symptoms or loss of function. At that time the wife told us that the oncologist in charge of the case in her country was aware that she was taking LifEscozul (escozul, blue scorpion venom) and had recommended to continue due to the good evolution of Lenin.
We had the next case report in March 2016, one year after starting LifEscozul. Lenin has continued well, showing no symptoms of disease progression 1 year and 7 months after his diagnosis.
And after one year on treatment with LifEscozul.
At the end of March we finally received the result of the MRI, to know after one year of treatment how Lenín was really doing.
The results of the MRI were astonishing even for the oncologist, according to the patient's wife. The examination showed no tumor activity in the brain, no recurrences, no tumor masses and no signs of cancer.
By February 2017.
Almost two years on treatment with LifEscozul (escozul, blue scorpion venom) the results remained the same: no presence of the tumor and his quality of life is high, his speech had improved considerably and he was better understood, he was also in very good spirits.
Fifth year on LifEscozul treatment
Mr. Lenin has remained disease free to date and his physical condition is getting better and better.
The oncologist has declared him cancer free and his communication skills have grown so much that we were able to record a video interview with him.
Brain cancers are usually very aggressive, even if they are operable, it is not always possible to remove all of them.
In Mr. Lenin's case it happened that way, it was possible to operate but it was not possible to remove all of it.
The doctors indicated that under this condition Mr. Lenin would have at most 2 years of survival.
His quality of life, before starting LifEscozul (escozul, blue scorpion venom) was poor, he suffered from continuous headaches, dizziness, loss of speech, among other symptoms.
When we started LifEscozul we focused on improving his quality of life and extending his survival time. But we had no illusions, we knew it was complicated and so we let him know.
Five years have passed and all forecasts were not fulfilled. Not only did Mr. Lenin improve his quality of life in a remarkable way: recovering his speech, his dizziness and headaches disappeared, but also the cancer disappeared.
Better results are impossible, and we live for these results.
We are the LifEscozul Group and Results Define Us.
José Daniel Ibarra
Evolution of the patient Jose Daniel Ibarra. Who entered the LifEscozul Protocol in 2017. He had previously suffered from colorectal cancer with liver metastases, and had been treated with chemotherapy, radiotherapy and surgery. View more